Literature DB >> 22621940

Neurocognitive speed and inconsistency in Parkinson's disease with and without incipient dementia: an 18-month prospective cohort study.

Cindy M de Frias1, Roger A Dixon, Richard Camicioli.   

Abstract

We examined two-wave longitudinal changes in two indicators of neurocognitive speed (i.e., mean rate, intraindividual variability) using one simple and three complex reaction time tasks. Participants included idiopathic Parkinson's disease (PD) patients, with and without incipient dementia, and normal controls. At baseline, there were 45 patients (26 men, 19 women) with idiopathic PD who ranged from 65 to 84 years (M = 71.3; SD = 4.5) and 47 matched controls (27 men, 20 women) who ranged from 65 to 84 years (M = 71.4; SD = 4.9). The 18-month longitudinal sample comprised of 74 returning participants (43 controls; 31 PD patients) who had no cognitive impairment or dementia at both waves. Ten of the 31 PD patients returning for Time 3 had dementia or cognitive impairment. These constituted the PD with incipient dementia (PDID) group. Repeated measures analyses of variance showed that the PD and PDID groups were slower over time on the reaction time tasks, whereas the controls improved their performance over time on all tasks. Inconsistency distinguished the two clinical groups (i.e., the PDID group but not the PD group became more inconsistent over time). Changes in neurocognitive speed and inconsistency may be valid clinical markers of PDID.

Entities:  

Mesh:

Year:  2012        PMID: 22621940      PMCID: PMC3804032          DOI: 10.1017/S1355617712000422

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  40 in total

1.  Risk and incidence of dementia in a cohort of older subjects with Parkinson's disease in the United Kingdom.

Authors:  Peter Hobson; Jolyon Meara
Journal:  Mov Disord       Date:  2004-09       Impact factor: 10.338

2.  Practice effect and beyond: reaction to novelty as an independent predictor of cognitive decline among older adults.

Authors:  Yana Suchy; Matthew L Kraybill; Emilie Franchow
Journal:  J Int Neuropsychol Soc       Date:  2010-11-15       Impact factor: 2.892

3.  Early, untreated Parkinson's disease patients show reaction time variability.

Authors:  Richard M Camicioli; Marguerite Wieler; Cindy M de Frias; W R Wayne Martin
Journal:  Neurosci Lett       Date:  2008-06-06       Impact factor: 3.046

Review 4.  A systematic review of prevalence studies of dementia in Parkinson's disease.

Authors:  Dag Aarsland; Julia Zaccai; Carol Brayne
Journal:  Mov Disord       Date:  2005-10       Impact factor: 10.338

5.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

6.  Intraindividual variability is related to cognitive change in older adults: evidence for within-person coupling.

Authors:  Allison A M Bielak; David F Hultsch; Esther Strauss; Stuart W S MacDonald; Michael A Hunter
Journal:  Psychol Aging       Date:  2010-09

Review 7.  The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.

Authors:  W R Gibb; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-06       Impact factor: 10.154

8.  Voxel-based morphometry reveals extra-nigral atrophy patterns associated with dopamine refractory cognitive and motor impairment in parkinsonism.

Authors:  Richard Camicioli; Myrlene Gee; Thomas P Bouchard; Nancy J Fisher; Chris C Hanstock; Derek J Emery; W R Wayne Martin
Journal:  Parkinsonism Relat Disord       Date:  2008-06-24       Impact factor: 4.891

9.  Visual reaction time and its relationship to neuropsychological test performance.

Authors:  L F Collins; C J Long
Journal:  Arch Clin Neuropsychol       Date:  1996       Impact factor: 2.813

10.  Predictive responses in Parkinson's disease: manual keypresses and saccadic eye movements to regular stimulus events.

Authors:  T Crawford; S Goodrich; L Henderson; C Kennard
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-09       Impact factor: 10.154

View more
  6 in total

1.  Elevated intraindividual variability in methamphetamine dependence is associated with poorer everyday functioning.

Authors:  Erin E Morgan; Katie L Doyle; Arpi Minassian; Brook L Henry; William Perry; Thomas D Marcotte; Steven Paul Woods; Igor Grant
Journal:  Psychiatry Res       Date:  2014-07-14       Impact factor: 3.222

2.  Cognitively elite, cognitively normal, and cognitively impaired aging: neurocognitive status and stability moderate memory performance.

Authors:  Roger A Dixon; Cindy M de Frias
Journal:  J Clin Exp Neuropsychol       Date:  2014-04-17       Impact factor: 2.475

3.  Quantitative assessment of finger tapping characteristics in mild cognitive impairment, Alzheimer's disease, and Parkinson's disease.

Authors:  David R Roalf; Petra Rupert; Dawn Mechanic-Hamilton; Laura Brennan; John E Duda; Daniel Weintraub; John Q Trojanowski; David Wolk; Paul J Moberg
Journal:  J Neurol       Date:  2018-04-04       Impact factor: 4.849

4.  Memantine and Cognition in Parkinson's Disease Dementia/Dementia With Lewy Bodies: A Meta-Analysis.

Authors:  Laura Brennan; Alexander Pantelyat; John E Duda; James F Morley; Daniel Weintraub; Jayne R Wilkinson; Paul J Moberg
Journal:  Mov Disord Clin Pract       Date:  2015-12-07

5.  Intra-individual reaction time variability in mild cognitive impairment and Alzheimer's disease: gender, processing load and speed factors.

Authors:  Michelle Phillips; Peter Rogers; Judy Haworth; Antony Bayer; Andrea Tales
Journal:  PLoS One       Date:  2013-06-10       Impact factor: 3.240

6.  Aberrant functional connectivity of resting state networks related to misperceptions and intra-individual variability in Parkinson's disease.

Authors:  Kristina Miloserdov; Carsten Schmidt-Samoa; Kathleen Williams; Christiane Anne Weinrich; Igor Kagan; Katrin Bürk; Claudia Trenkwalder; Mathias Bähr; Melanie Wilke
Journal:  Neuroimage Clin       Date:  2019-11-05       Impact factor: 4.881

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.